FGFR4
Reactivité: Humain, Rat
ELISA, IHC (p), IF (cc), IF (p), ICC, IHC (fro)
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Western Blot (1:1000) Immunohistochemistry (1:50-100) Flow cytometry (1:10-50) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Jézéquel, Campion, Joalland, Millour, Dravet, Classe, Delecroix, Deporte, Fumoleau, Ricolleau: "G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis." dans: British journal of cancer, Vol. 90, Issue 1, pp. 189-93, (2004) (PubMed).
Qian, Sano, Asa, Yamada, Horiguchi, Tashiro, Li, Hirokawa, Kovacs, Ezzat: "Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness." dans: The Journal of clinical endocrinology and metabolism, Vol. 89, Issue 4, pp. 1904-11, (2004) (PubMed).
Yu, Asa, Weigel, Ezzat: "Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4." dans: The Journal of biological chemistry, Vol. 278, Issue 22, pp. 19597-602, (2003) (PubMed).